Discover, Engineer, Translate
The Antibody & Immune Modality (AIM) lab accelerates the discovery of fully human antibodies, with particular strengths in single-domain formats. We work through broad collaborations to engineer these binders into diverse therapeutic modalities and apply AI-enabled workflows to accelerate design, optimization, and translation.